Cargando…
von Willebrand factor in iris vasculature of glaucoma patients
BACKGROUND: Previous reports have indicated the role of endothelium disturbances, as expressed by von Willebrand factor (vWF) release, in pathophysiology of glaucoma. The objective of this study was to investigate the vWF expression in iris vasculature of patients with primary open-angle glaucoma (P...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072563/ https://www.ncbi.nlm.nih.gov/pubmed/24954072 http://dx.doi.org/10.12659/MSM.890176 |
_version_ | 1782322980421894144 |
---|---|
author | Rokicki, Wojciech Żaba, Małgorzata Mrukwa-Kominek, Ewa Wyględowska-Promieńska, Dorota Brzozowa, Marlena Reichman-Warmusz, Edyta Wojnicz, Romuald |
author_facet | Rokicki, Wojciech Żaba, Małgorzata Mrukwa-Kominek, Ewa Wyględowska-Promieńska, Dorota Brzozowa, Marlena Reichman-Warmusz, Edyta Wojnicz, Romuald |
author_sort | Rokicki, Wojciech |
collection | PubMed |
description | BACKGROUND: Previous reports have indicated the role of endothelium disturbances, as expressed by von Willebrand factor (vWF) release, in pathophysiology of glaucoma. The objective of this study was to investigate the vWF expression in iris vasculature of patients with primary open-angle glaucoma (POAG). MATERIAL/METHODS: Immunohistochemistry of vWF expression was performed on cryostat sections of samples collected at the time of peripheral iridectomy and controls collected from dead donors. RESULTS: Twenty-seven Caucasians age 66.6±3.7 with 5.8±3.7-year history of treated PAOG and 10 controls age 62.2±1.92 with no history of glaucoma. The percentage of patients who presented normal and up-regulation of vWF phenotype expression differed statistically between examined and control groups: 48% versus 100% (p=0.035, chi-square test with Yates’ correction). Sex, age, glaucoma duration, and visual field quantitative indices had no impact on vWF expression. A significant correlation between mean pre-surgery intraocular pressure and vWF expression was found (Spearman r=0.42, p=0.03). CONCLUSIONS: Considering the results, it may be suggested that vWF is actively involved in the pathophysiology of glaucoma. |
format | Online Article Text |
id | pubmed-4072563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-40725632014-06-27 von Willebrand factor in iris vasculature of glaucoma patients Rokicki, Wojciech Żaba, Małgorzata Mrukwa-Kominek, Ewa Wyględowska-Promieńska, Dorota Brzozowa, Marlena Reichman-Warmusz, Edyta Wojnicz, Romuald Med Sci Monit Clinical Research BACKGROUND: Previous reports have indicated the role of endothelium disturbances, as expressed by von Willebrand factor (vWF) release, in pathophysiology of glaucoma. The objective of this study was to investigate the vWF expression in iris vasculature of patients with primary open-angle glaucoma (POAG). MATERIAL/METHODS: Immunohistochemistry of vWF expression was performed on cryostat sections of samples collected at the time of peripheral iridectomy and controls collected from dead donors. RESULTS: Twenty-seven Caucasians age 66.6±3.7 with 5.8±3.7-year history of treated PAOG and 10 controls age 62.2±1.92 with no history of glaucoma. The percentage of patients who presented normal and up-regulation of vWF phenotype expression differed statistically between examined and control groups: 48% versus 100% (p=0.035, chi-square test with Yates’ correction). Sex, age, glaucoma duration, and visual field quantitative indices had no impact on vWF expression. A significant correlation between mean pre-surgery intraocular pressure and vWF expression was found (Spearman r=0.42, p=0.03). CONCLUSIONS: Considering the results, it may be suggested that vWF is actively involved in the pathophysiology of glaucoma. International Scientific Literature, Inc. 2014-06-23 /pmc/articles/PMC4072563/ /pubmed/24954072 http://dx.doi.org/10.12659/MSM.890176 Text en © Med Sci Monit, 2014 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License |
spellingShingle | Clinical Research Rokicki, Wojciech Żaba, Małgorzata Mrukwa-Kominek, Ewa Wyględowska-Promieńska, Dorota Brzozowa, Marlena Reichman-Warmusz, Edyta Wojnicz, Romuald von Willebrand factor in iris vasculature of glaucoma patients |
title | von Willebrand factor in iris vasculature of glaucoma patients |
title_full | von Willebrand factor in iris vasculature of glaucoma patients |
title_fullStr | von Willebrand factor in iris vasculature of glaucoma patients |
title_full_unstemmed | von Willebrand factor in iris vasculature of glaucoma patients |
title_short | von Willebrand factor in iris vasculature of glaucoma patients |
title_sort | von willebrand factor in iris vasculature of glaucoma patients |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072563/ https://www.ncbi.nlm.nih.gov/pubmed/24954072 http://dx.doi.org/10.12659/MSM.890176 |
work_keys_str_mv | AT rokickiwojciech vonwillebrandfactorinirisvasculatureofglaucomapatients AT zabamałgorzata vonwillebrandfactorinirisvasculatureofglaucomapatients AT mrukwakominekewa vonwillebrandfactorinirisvasculatureofglaucomapatients AT wygledowskapromienskadorota vonwillebrandfactorinirisvasculatureofglaucomapatients AT brzozowamarlena vonwillebrandfactorinirisvasculatureofglaucomapatients AT reichmanwarmuszedyta vonwillebrandfactorinirisvasculatureofglaucomapatients AT wojniczromuald vonwillebrandfactorinirisvasculatureofglaucomapatients |